POMPANO BEACH, FLORIDA., August 16,2022 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today announced it will host a conference call to discuss financial results for the quarter ended June30, 2022 and provide a corporate update on Monday, August22, 2022, at 4:30 pm EDT.
POMPANO BEACH, FLORIDA., May 16,2022 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today reported financial results for the quarter ended March 31, 2022.
BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care market today reported financial results for the year ended December 31, 2021.
BioStem Technologies, Inc. and its subsidiary Blue Tech Industries, Inc. (d/b/a BioStem Life Sciences), a Certified VOSB (Veteran-Owned Small Business), are proud to announce a 2021 Veterans Day Fundraiser to support America's VetDogs®. To honor those who have served our country, BioStem Technologies will be donating 10% of proceeds from all sales November 10-11th, 2021, to America's VetDogs®.
